A promising medication, the drug , is generating significant attention within the healthcare community as a possible solution for excess weight . Developed by the company , it’s a dual GIP and GLP-1 receptor agonist, meaning it operates on two distinct pathways to regulate food intake and promote metabolic expenditure . Early clinical results ha… Read More